Immunohistochemistry and qRT-PCR showed BIM levels (protein and mRNA) increased in tumours from mice receiving Cisplatin, and unexpectedly, MCL-1 levels were reduced in tumours following A-1331852 treatment (Fig. S8A, B). This evidence concerns the gene MCL1 and neoplasm.